Whereas mice that had rejected the original tumor in the absence of NK cells rejected the tumor rechallenge, mice which had been depleted of CD4 or CD8 T cells during the primary therapy were significantly more likely to succumb to tumor upon rechallenge (Figure 5c, P=0.018, P=0.004, respectively). This evidence concerns the gene CD8A and neoplasm.